New NACDS Report Tells Story of Pharmacies’ Continued and Pivotal Role in Serving Patients During Health Emergencies and Every Day The third in a series of reports shows how valuable experiences and lessons learned during the COVID pandemic response can help inform policy decisions and future pandemic planning and preparedness

2021-12-01T12:11:54-05:00Categories: Press Release|Tags: , , , , , |

The third in a series of reports shows how valuable experiences and lessons learned during the COVID pandemic response can help inform policy decisions and future pandemic planning and preparedness.

NACDS Applauds Eighth Circuit Decision Upholding North Dakota Law Regulating PBMs Court reinforces and strengthens landmark U.S. Supreme Court ruling in pivotal Rutledge case

2021-11-18T13:31:33-05:00Categories: Press Release|Tags: , , , |

NACDS is hailing a decision by the Eighth Circuit of the U.S. Court of Appeals yesterday which upholds a North Dakota law prioritizing the health and safety of patients by promoting the economic viability of local pharmacies.

New NACDS Report Demonstrates How Leveraging the Expertise and Accessibility of Pharmacists Will Help Support Broader Healthcare Transformation to Advance Quality and Value Calls on the Center for Medicare and Medicaid Innovation to integrate pharmacies and pharmacists into value-based programs and alternative payment models to accelerate mission toward better outcomes and lower costs

2021-11-18T10:00:46-05:00Categories: Press Release|Tags: , , , , , , |

Calls on the Center for Medicare and Medicaid Innovation to integrate pharmacies and pharmacists into value-based programs and alternative payment models to accelerate mission toward better outcomes and lower costs.

An “Obvious Miss” for Seniors’ Drug Savings: NACDS Hits Lack of Pharmacy DIR Fee Reform in Current Budget Reconciliation Bill

2021-11-10T10:57:15-05:00Categories: Press Release|Tags: , , , , |

NACDS today said that omitting pharmacy direct and indirect remuneration (DIR) fee reforms from the Build Back Better Act budget reconciliation bill will deprive Medicare beneficiaries of between $7.1 and $9.2 billion over 10 years in reduced cost-sharing for prescription drugs, according to Centers for Medicare and Medicaid Services (CMS) estimates.

Go to Top